Home › NDC Lookup › RxCUI directory › RxCUI 897025

12 HR dalfampridine 10 MG Extended Release Oral Tablet [Ampyra] — RxCUI 897025

RxNorm drug concept · Semantic branded drug
RxCUI 897025 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI897025
Official name12 HR dalfampridine 10 MG Extended Release Oral Tablet [Ampyra]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as12 HR Ampyra 10 MG Extended Release Oral Tablet; Ampyra 10 MG 12HR Extended Release Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)290 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dalfampridine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dalfampridine is designed specifically to improve walking in adults with MS. It works by helping electrical signals travel more effectively through nerve fibers that have been dama...
  • What exactly does dalfampridine do — will it help me walk better?
  • You take one tablet twice a day, spacing your doses roughly 12 hours apart — for example, morning and evening. Food doesn't really matter; you can take it with or without a meal. T...
  • How do I take it — does it matter if I eat first?
📖 Read our full Dalfampridine guide →

🕸️ Concept Web — How 12 HR dalfampridine 10 MG Extended Release Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 12 HR dalfampridine 10 MG Extended Release Oral Tablet [Ampyra] RxCUI 897025

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dalfampridine 897018
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ampyra 897022
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dalfampridine Extended Release Oral Tablet 897020
    • Dalfampridine Oral Product 1156648
    • Dalfampridine Pill 1156649
    • Dalfampridine Extended Release Oral Tablet [Ampyra] 897024
    • Ampyra Oral Product 1174198
    • Ampyra Pill 1174199
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Dalfampridine 10 MG [Ampyra] SBDC · 897023
  • Dalfampridine Extended Release Oral Tablet [Ampyra] SBDF · 897024
  • Ampyra Oral Product SBDG · 1174198
  • Ampyra Pill SBDG · 1174199
  • Ampyra BN · 897022

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 897025 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00259-5010-60 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0259-5... AMPYRA Merz Pharmaceuticals, LLC 2010-03-01
10144-0427-60 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10144-... AMPYRA Merz Pharmaceuticals, LLC 2010-03-01
Observed labelers: Merz Pharmaceuticals, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.